BASAL CELL NAEVUS SYNDROME

BASAL CELL NAEVUS SYNDROME was reported 23 times

BASAL CELL NAEVUS SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DACTINOMYCIN 6 0.0027
1 VISMODEGIB 3 0.0003
2 IFOSFAMIDE FOR INJECTION 7 0.0003
3 ETOPOSIDE 8 0.0001
4 THIOTEPA 1 0.0001
5 ADALIMUMAB-FKJP 4 0.0001
6 ADALIMUMAB-AATY 4 0.0001
7 MECLIZINE HCL 12.5 MG 1 0.0001
8 ADALIMUMAB-ADAZ 4 0.0001
9 CARBOPLATIN 7 0.0001
10 MECLIZINE HYDROCHLORIDE 1 0.0001
11 ARMODAFINIL 1 0.0000
12 MELPHALAN HYDROCHLORIDE 1 0.0000
13 SUMATRIPTAN SUCCINATE 1 0.0000
14 VINCRISTINE SULFATE 1 0.0000
15 DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE 1 0.0000
16 LEVETIRACETAM ORAL 2 0.0000
17 LEVETIRACETAM INJECTION 2 0.0000
18 DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE 1 0.0000
19 ESTRADIOL TRANSDERMAL 1 0.0000
20 MELOXICAM 1 0.0000
21 SODIUM OXYBATE 1 0.0000
22 TACROLIMUS OINTMENT 0.1% 2 0.0000
23 TACROLIMUS EXTENDED-RELEASE CAPSULES 2 0.0000
24 LEVETIRACETAM 2 0.0000
25 MYCOPHENOLATE MOFETIL 2 0.0000
26 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 2 0.0000
27 CISPLATIN 1 0.0000
28 TACROLIMUS 2 0.0000
29 UPADACITINIB 1 0.0000
30 ESTRADIOL 1 0.0000
31 DOXORUBICIN 1 0.0000
32 USTEKINUMAB 1 0.0000
33 LORATADINE 1 0.0000
34 SERTRALINE HYDROCHLORIDE 1 0.0000
35 ONDANSETRON HYDROCHLORIDE 1 0.0000
36 FLUTICASONE PROPIONATE 1 0.0000
37 CELECOXIB 1 0.0000
38 ADALIMUMAB 5 0.0000
39 ESCITALOPRAM 1 0.0000
40 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
41 CYCLOPHOSPHAMIDE 1 0.0000
42 ALPRAZOLAM 1 0.0000
43 SIMVASTATIN 1 0.0000
44 PREDNISONE 2 0.0000
45 PREGABALIN 1 0.0000
46 ALBUTEROL SULFATE 1 0.0000
47 GABAPENTIN 1 0.0000
48 METHOTREXATE SODIUM 1 0.0000